{"id":232,"date":"2019-11-14T21:05:23","date_gmt":"2019-11-14T21:05:23","guid":{"rendered":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/chapter\/5-14-xanthine-derivatives\/"},"modified":"2025-01-16T22:26:07","modified_gmt":"2025-01-16T22:26:07","slug":"5-14-xanthine-derivatives","status":"publish","type":"chapter","link":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/chapter\/5-14-xanthine-derivatives\/","title":{"raw":"5.14 Xanthine Derivatives","rendered":"5.14 Xanthine Derivatives"},"content":{"raw":"Theophylline is a xanthine derivative.\n\n<strong>Mechanism of Action: <\/strong>Theophylline relaxes bronchial smooth muscle by inhibition of the enzyme phosphodiesterase and suppresses airway responsiveness to stimuli that cause bronchoconstriction.\n\n<strong>Indications: <\/strong>Theophylline is used for the long-term management of persistent asthma that is unresponsive to beta-agonists or inhaled corticosteroids.\n\n<strong>Nursing Considerations: <\/strong>Nurses should remind patients that xanthine derivatives are not quick relief medications for asthma attacks. Due to potential CNS stimulation, administer this medication in the morning\u00a0 when possible.\n\n<strong>Side Effects\/Adverse Effects: <\/strong>Theophylline can cause nausea, vomiting, CNS stimulation, nervousness, and insomnia.<sup>[footnote]Frandsen, G., &amp; Pennington, S. (2018). <em>Abrams\u2019 clinical drug: Rationales for nursing practice <\/em>(11th ed.). Wolters Kluwer.[\/footnote]<\/sup>\n\n<strong>Health Teaching &amp; Health Promotion: <\/strong>Patients should be sure to take medications as prescribed at appropriate intervals. They should avoid irritants, caffeine, and drink fluids to help thin secretions. Patients will need serum blood levels tested every six to twelve months.<sup>[footnote]uCentral from Unbound Medicine. <a href=\"https:\/\/www.unboundmedicine.com\/ucentral\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.unboundmedicine.com\/ucentral<\/a>[\/footnote]<\/sup> Due to potential CNS stimulation, suggest taking this medication in the morning.\n\nNow let's take a closer look at the medication grid on theophylline in Table 5.14.<sup>[footnote]This work is a derivative of\u00a0<a href=\"https:\/\/www.oercommons.org\/authoring\/54330-pharmacology-notes-nursing-implications-for-clinic\/view\" target=\"_blank\" rel=\"noopener noreferrer\">Pharmacology Notes: Nursing Implications for Clinical Practice<\/a>\u00a0by\u00a0<a href=\"https:\/\/www.oercommons.org\/profile\/213497\" target=\"_blank\" rel=\"noopener noreferrer\">Gloria Velarde<\/a>\u00a0licensed under\u00a0<a href=\"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY-NC-SA 4.0<\/a>[\/footnote],[footnote]Frandsen, G., &amp; Pennington, S. (2018). <em>Abrams\u2019 clinical drug: Rationales for nursing practice\u00a0<\/em>(11th ed.). Wolters Kluwer.[\/footnote],[footnote]This work is a derivative of\u00a0<a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/\" target=\"_blank\" rel=\"noopener noreferrer\">DailyMed<\/a>\u00a0by\u00a0<a href=\"https:\/\/www.nlm.nih.gov\/\" target=\"_blank\" rel=\"noopener noreferrer\">U.S. National Library of Medicine<\/a> in the <a href=\"https:\/\/creativecommons.org\/share-your-work\/public-domain\/\" target=\"_blank\" rel=\"noopener noreferrer\">Public Domain<\/a>. [\/footnote]<\/sup>\n\nTable 5.14 Theophylline Medication Grid\n<table class=\"grid\" border=\"0\">\n<tbody>\n<tr>\n<th class=\"shaded\" style=\"width: 132.063px\" scope=\"col\">\n<h5><strong>Class\/Subclass<\/strong><\/h5>\n<\/th>\n<th class=\"shaded\" style=\"width: 165.063px\" scope=\"col\">\n<h5><strong>Prototype\/Generic<\/strong><\/h5>\n<\/th>\n<th class=\"shaded\" style=\"width: 390.063px\" scope=\"col\">\n<h5><strong>Nursing Considerations<\/strong><\/h5>\n<\/th>\n<th class=\"shaded\" style=\"width: 384.063px\" scope=\"col\">\n<h5><strong>Therapeutic Effects<\/strong><\/h5>\n<\/th>\n<th class=\"shaded\" style=\"width: 229.063px\" scope=\"col\">\n<h5><strong>Side\/Adverse Effects<\/strong><\/h5>\n<\/th>\n<\/tr>\n<tr>\n<th style=\"width: 132.063px\" scope=\"row\">Xanthine<\/th>\n<td style=\"width: 165.063px\"><a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=038c2b07-8028-4dc4-847c-adafe1b0e81a\" target=\"_blank\" rel=\"noopener noreferrer\">theophylline<\/a><\/td>\n<td style=\"width: 390.063px\">Avoid caffeine\n\nRequires evaluation of therapeutic blood level to prevent toxicity\n\nAdminister this medication in the morning, if possible, due to potential CNS stimulation<\/td>\n<td style=\"width: 384.063px\">Long-term treatment of chronic asthma and COPD unresponsive to other treatment<\/td>\n<td style=\"width: 229.063px\">GI: Nausea and vomiting\n\nCNS stimulation\n\nNervousness and insomnia<\/td>\n<\/tr>\n<\/tbody>\n<\/table>","rendered":"<p>Theophylline is a xanthine derivative.<\/p>\n<p><strong>Mechanism of Action: <\/strong>Theophylline relaxes bronchial smooth muscle by inhibition of the enzyme phosphodiesterase and suppresses airway responsiveness to stimuli that cause bronchoconstriction.<\/p>\n<p><strong>Indications: <\/strong>Theophylline is used for the long-term management of persistent asthma that is unresponsive to beta-agonists or inhaled corticosteroids.<\/p>\n<p><strong>Nursing Considerations: <\/strong>Nurses should remind patients that xanthine derivatives are not quick relief medications for asthma attacks. Due to potential CNS stimulation, administer this medication in the morning\u00a0 when possible.<\/p>\n<p><strong>Side Effects\/Adverse Effects: <\/strong>Theophylline can cause nausea, vomiting, CNS stimulation, nervousness, and insomnia.<sup><a class=\"footnote\" title=\"Frandsen, G., &amp; Pennington, S. (2018). Abrams\u2019 clinical drug: Rationales for nursing practice (11th ed.). Wolters Kluwer.\" id=\"return-footnote-232-1\" href=\"#footnote-232-1\" aria-label=\"Footnote 1\"><sup class=\"footnote\">[1]<\/sup><\/a><\/sup><\/p>\n<p><strong>Health Teaching &amp; Health Promotion: <\/strong>Patients should be sure to take medications as prescribed at appropriate intervals. They should avoid irritants, caffeine, and drink fluids to help thin secretions. Patients will need serum blood levels tested every six to twelve months.<sup><a class=\"footnote\" title=\"uCentral from Unbound Medicine. https:\/\/www.unboundmedicine.com\/ucentral\" id=\"return-footnote-232-2\" href=\"#footnote-232-2\" aria-label=\"Footnote 2\"><sup class=\"footnote\">[2]<\/sup><\/a><\/sup> Due to potential CNS stimulation, suggest taking this medication in the morning.<\/p>\n<p>Now let&#8217;s take a closer look at the medication grid on theophylline in Table 5.14.<sup><a class=\"footnote\" title=\"This work is a derivative of\u00a0Pharmacology Notes: Nursing Implications for Clinical Practice\u00a0by\u00a0Gloria Velarde\u00a0licensed under\u00a0CC BY-NC-SA 4.0\" id=\"return-footnote-232-3\" href=\"#footnote-232-3\" aria-label=\"Footnote 3\"><sup class=\"footnote\">[3]<\/sup><\/a>,<a class=\"footnote\" title=\"Frandsen, G., &amp; Pennington, S. (2018). Abrams\u2019 clinical drug: Rationales for nursing practice\u00a0(11th ed.). Wolters Kluwer.\" id=\"return-footnote-232-4\" href=\"#footnote-232-4\" aria-label=\"Footnote 4\"><sup class=\"footnote\">[4]<\/sup><\/a>,<a class=\"footnote\" title=\"This work is a derivative of\u00a0DailyMed\u00a0by\u00a0U.S. National Library of Medicine in the Public Domain.\" id=\"return-footnote-232-5\" href=\"#footnote-232-5\" aria-label=\"Footnote 5\"><sup class=\"footnote\">[5]<\/sup><\/a><\/sup><\/p>\n<p>Table 5.14 Theophylline Medication Grid<\/p>\n<table class=\"grid\">\n<tbody>\n<tr>\n<th class=\"shaded\" style=\"width: 132.063px\" scope=\"col\">\n<h5><strong>Class\/Subclass<\/strong><\/h5>\n<\/th>\n<th class=\"shaded\" style=\"width: 165.063px\" scope=\"col\">\n<h5><strong>Prototype\/Generic<\/strong><\/h5>\n<\/th>\n<th class=\"shaded\" style=\"width: 390.063px\" scope=\"col\">\n<h5><strong>Nursing Considerations<\/strong><\/h5>\n<\/th>\n<th class=\"shaded\" style=\"width: 384.063px\" scope=\"col\">\n<h5><strong>Therapeutic Effects<\/strong><\/h5>\n<\/th>\n<th class=\"shaded\" style=\"width: 229.063px\" scope=\"col\">\n<h5><strong>Side\/Adverse Effects<\/strong><\/h5>\n<\/th>\n<\/tr>\n<tr>\n<th style=\"width: 132.063px\" scope=\"row\">Xanthine<\/th>\n<td style=\"width: 165.063px\"><a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=038c2b07-8028-4dc4-847c-adafe1b0e81a\" target=\"_blank\" rel=\"noopener noreferrer\">theophylline<\/a><\/td>\n<td style=\"width: 390.063px\">Avoid caffeine<\/p>\n<p>Requires evaluation of therapeutic blood level to prevent toxicity<\/p>\n<p>Administer this medication in the morning, if possible, due to potential CNS stimulation<\/td>\n<td style=\"width: 384.063px\">Long-term treatment of chronic asthma and COPD unresponsive to other treatment<\/td>\n<td style=\"width: 229.063px\">GI: Nausea and vomiting<\/p>\n<p>CNS stimulation<\/p>\n<p>Nervousness and insomnia<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<hr class=\"before-footnotes clear\" \/><div class=\"footnotes\"><ol><li id=\"footnote-232-1\">Frandsen, G., &amp; Pennington, S. (2018). <em>Abrams\u2019 clinical drug: Rationales for nursing practice <\/em>(11th ed.). Wolters Kluwer. <a href=\"#return-footnote-232-1\" class=\"return-footnote\" aria-label=\"Return to footnote 1\">&crarr;<\/a><\/li><li id=\"footnote-232-2\">uCentral from Unbound Medicine. <a href=\"https:\/\/www.unboundmedicine.com\/ucentral\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.unboundmedicine.com\/ucentral<\/a> <a href=\"#return-footnote-232-2\" class=\"return-footnote\" aria-label=\"Return to footnote 2\">&crarr;<\/a><\/li><li id=\"footnote-232-3\">This work is a derivative of\u00a0<a href=\"https:\/\/www.oercommons.org\/authoring\/54330-pharmacology-notes-nursing-implications-for-clinic\/view\" target=\"_blank\" rel=\"noopener noreferrer\">Pharmacology Notes: Nursing Implications for Clinical Practice<\/a>\u00a0by\u00a0<a href=\"https:\/\/www.oercommons.org\/profile\/213497\" target=\"_blank\" rel=\"noopener noreferrer\">Gloria Velarde<\/a>\u00a0licensed under\u00a0<a href=\"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY-NC-SA 4.0<\/a> <a href=\"#return-footnote-232-3\" class=\"return-footnote\" aria-label=\"Return to footnote 3\">&crarr;<\/a><\/li><li id=\"footnote-232-4\">Frandsen, G., &amp; Pennington, S. (2018). <em>Abrams\u2019 clinical drug: Rationales for nursing practice\u00a0<\/em>(11th ed.). Wolters Kluwer. <a href=\"#return-footnote-232-4\" class=\"return-footnote\" aria-label=\"Return to footnote 4\">&crarr;<\/a><\/li><li id=\"footnote-232-5\">This work is a derivative of\u00a0<a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/\" target=\"_blank\" rel=\"noopener noreferrer\">DailyMed<\/a>\u00a0by\u00a0<a href=\"https:\/\/www.nlm.nih.gov\/\" target=\"_blank\" rel=\"noopener noreferrer\">U.S. National Library of Medicine<\/a> in the <a href=\"https:\/\/creativecommons.org\/share-your-work\/public-domain\/\" target=\"_blank\" rel=\"noopener noreferrer\">Public Domain<\/a>.  <a href=\"#return-footnote-232-5\" class=\"return-footnote\" aria-label=\"Return to footnote 5\">&crarr;<\/a><\/li><\/ol><\/div>","protected":false},"author":83,"menu_order":14,"template":"","meta":{"pb_show_title":"on","pb_short_title":"","pb_subtitle":"","pb_authors":[],"pb_section_license":""},"chapter-type":[48],"contributor":[],"license":[],"class_list":["post-232","chapter","type-chapter","status-publish","hentry","chapter-type-numberless"],"part":186,"_links":{"self":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/232","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters"}],"about":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/types\/chapter"}],"author":[{"embeddable":true,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/users\/83"}],"version-history":[{"count":1,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/232\/revisions"}],"predecessor-version":[{"id":233,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/232\/revisions\/233"}],"part":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/parts\/186"}],"metadata":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/232\/metadata\/"}],"wp:attachment":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/media?parent=232"}],"wp:term":[{"taxonomy":"chapter-type","embeddable":true,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapter-type?post=232"},{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/contributor?post=232"},{"taxonomy":"license","embeddable":true,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/license?post=232"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}